{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T21:07:16Z","timestamp":1784408836873,"version":"3.55.0"},"reference-count":24,"publisher":"Japanese Society of Internal Medicine","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,2,1]]},"DOI":"10.2169\/internalmedicine.5587-25","type":"journal-article","created":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T22:07:50Z","timestamp":1752098870000},"page":"479-484","source":"Crossref","is-referenced-by-count":1,"title":["Thyroid Storm Following Alemtuzumab-based Allogeneic Stem Cell Transplantation: A Case Report and Literature Review"],"prefix":"10.2169","volume":"65","author":[{"given":"Sakura","family":"Saigusa","sequence":"first","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Aichi Medical University School of Medicine, Japan"},{"name":"Hematopoietic Cell Transplantation Center, Aichi Medical University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaori","family":"Uchino","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Aichi Medical University School of Medicine, Japan"},{"name":"Hematopoietic Cell Transplantation Center, Aichi Medical University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideshige","family":"Seki","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Aichi Medical University School of Medicine, Japan"},{"name":"Hematopoietic Cell Transplantation Center, Aichi Medical University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukie","family":"Sugita","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Aichi Medical University School of Medicine, Japan"},{"name":"Hematopoietic Cell Transplantation Center, Aichi Medical University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuto","family":"Isaji","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Aichi Medical University School of Medicine, Japan"},{"name":"Hematopoietic Cell Transplantation Center, Aichi Medical University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Iida","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Aichi Medical University School of Medicine, Japan"},{"name":"Hematopoietic Cell Transplantation Center, Aichi Medical University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saki","family":"Shinohara","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Aichi Medical University School of Medicine, Japan"},{"name":"Hematopoietic Cell Transplantation Center, Aichi Medical University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Horio","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Aichi Medical University School of Medicine, Japan"},{"name":"Hematopoietic Cell Transplantation Center, Aichi Medical University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satsuki","family":"Murakami","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Aichi Medical University School of Medicine, Japan"},{"name":"Hematopoietic Cell Transplantation Center, Aichi Medical University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shohei","family":"Mizuno","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Aichi Medical University School of Medicine, Japan"},{"name":"Hematopoietic Cell Transplantation Center, Aichi Medical University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Ikegame","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Aichi Medical University School of Medicine, Japan"},{"name":"Hematopoietic Cell Transplantation Center, Aichi Medical University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Hanamura","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Aichi Medical University School of Medicine, Japan"},{"name":"Hematopoietic Cell Transplantation Center, Aichi Medical University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichiro","family":"Mokuno","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine, Aichi Medical University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Takagi","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine, Aichi Medical University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiki","family":"Hirano","sequence":"additional","affiliation":[{"name":"Department of Hematology, National Hospital Organization Nagoya Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroatsu","family":"Iida","sequence":"additional","affiliation":[{"name":"Department of Hematology, National Hospital Organization Nagoya Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Nakao","sequence":"additional","affiliation":[{"name":"Department of Hematology, Faculty of Medicine, Institute of Medical Pharmaceutical and Health Sciences, Kanazawa University, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiyoshi","family":"Takami","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Aichi Medical University School of Medicine, Japan"},{"name":"Hematopoietic Cell Transplantation Center, Aichi Medical University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Young NS. Aplastic anemia. N Engl J Med 379: 1643-1656, 2018.","DOI":"10.1056\/NEJMra1413485"},{"key":"2","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1182\/blood.V89.10.3691","volume":"89","author":"S Nakao","year":"1997","unstructured":"2. Nakao S, Takami A, Takamatsu H, et al. Isolation of a T-cell clone showing HLA-DRB1*0405-restricted cytotoxicity for hematopoietic cells in a patient with aplastic anemia. Blood 89: 3691-3699, 1997.","journal-title":"Blood","ISSN":"https:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Nakao S. Diagnosis of immune pathophysiology in patients with bone marrow failure. Int J Hematol 119: 231-239, 2024.","DOI":"10.1007\/s12185-022-03519-1"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Marsh JC, Gupta V, Lim Z, et al. Alemtuzumab with fludarabine and cyclophosphamide reduces chronic graft-versus-host disease after allogeneic stem cell transplantation for acquired aplastic anemia. Blood 118: 2351-2357, 2011.","DOI":"10.1182\/blood-2010-12-327536"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Gandhi S, Kulasekararaj AG, Mufti GJ, Marsh JC. Allogeneic stem cell transplantation using alemtuzumab-containing regimens in severe aplastic anemia. Int J Hematol 97: 573-580, 2013.","DOI":"10.1007\/s12185-013-1333-9"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Pratt G, Kinsey SE. Remission of severe, intractable autoimmune haemolytic anaemia following matched unrelated donor transplantation. Bone Marrow Transplant 28: 791-793, 2001.","DOI":"10.1038\/sj.bmt.1703232"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Kako S, Kanda Y, Oshima K, et al. Late onset of autoimmune hemolytic anemia and pure red cell aplasia after allogeneic hematopoietic stem cell transplantation using in vivo alemtuzumab. Am J Hematol 83: 247-249, 2008.","DOI":"10.1002\/ajh.21086"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Williams KM, Dietzen D, Hassoun AA, Fennoy I, Bhatia M. Autoimmune thyroid disease following alemtuzumab therapy and hematopoietic cell transplantation in pediatric patients with sickle cell disease. Pediatr Blood Cancer 61: 2307-2309, 2014.","DOI":"10.1002\/pbc.25102"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Cima LN, Lambrescu IM, Stejereanu L, Colita A, Or R, Fica S. Graves&apos; orbitopathy after allogeneic bone marrow transplantation in a patient with Fanconi anemia - side effect of alemtuzumab therapy? Clin Case Rep 6: 867-870, 2018.","DOI":"10.1002\/ccr3.1486"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Yanir AD, Hanson IC, Shearer WT, et al. High incidence of autoimmune disease after hematopoietic stem cell transplantation for chronic granulomatous disease. Biol Blood Marrow Transplant 24: 1643-1650, 2018.","DOI":"10.1016\/j.bbmt.2018.03.029"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Lloyd R, Nikolousis E, Kishore B, et al. Autoimmune cytopenias developing late post alemtuzumab-based allogeneic stem cell transplantation: presentation of short case series from a transplant center. Cell Transplant 29: 963689720950641, 2020.","DOI":"10.1177\/0963689720950641"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Morelle G, Castelle M, Pinto G, et al. Sustained remission after haploidentical bone marrow transplantation in a child with refractory systemic juvenile idiopathic arthritis. Pediatr Rheumatol Online J 19: 27, 2021.","DOI":"10.1186\/s12969-021-00523-3"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Mandava M, Lew J, Tisdale JF, Limerick E, Fitzhugh CD, Hsieh MM. Thyroid and adrenal dysfunction in hemoglobinopathies before and after allogeneic hematopoietic cell transplant. J Endocr Soc 7: bvad134, 2023.","DOI":"10.1210\/jendso\/bvad134"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Sheth VS, Potter V, Gandhi SA, et al. Similar outcomes of alemtuzumab-based hematopoietic cell transplantation for SAA patients older or younger than 50 years. Blood Adv 3: 3070-3079, 2019.","DOI":"10.1182\/bloodadvances.2019000480"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. van Besien K, Dew A, Lin S, et al. Patterns and kinetics of T-cell chimerism after allo transplant with alemtuzumab-based conditioning: mixed chimerism protects from GVHD, but does not portend disease recurrence. Leuk Lymphoma 50: 1809-1817, 2009.","DOI":"10.3109\/10428190903200790"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Burch HB, Wartofsky L. Life-threatening thyrotoxicosis. Thyroid storm. Endocrinol Metab Clin North Am 22: 263-277, 1993.","DOI":"10.1016\/S0889-8529(18)30165-8"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Satoh T, Isozaki O, Suzuki A, et al. 2016 Guidelines for the management of thyroid storm from The Japan Thyroid Association and Japan Endocrine Society (First edition). Endocr J 63: 1025-1064, 2016.","DOI":"10.1507\/endocrj.EJ16-0336"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Scappaticcio L, Castellana M, Virili C, et al. Alemtuzumab-induced thyroid events in multiple sclerosis: a systematic review and meta-analysis. J Endocrinol Invest 43: 219-229, 2020.","DOI":"10.1007\/s40618-019-01105-7"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Jones JL, Thompson SA, Loh P, et al. Human autoimmunity after lymphocyte depletion is caused by homeostatic T-cell proliferation. Proc Natl Acad Sci U S A 110: 20200-20205, 2013.","DOI":"10.1073\/pnas.1313654110"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Sun Z, Zhong W, Lu X, et al. Association of Graves&apos; disease and prevalence of circulating IFN-\u03b3-producing CD28<sup>-<\/sup> T cells. J Clin Immunol 28: 464-472, 2008.","DOI":"10.1007\/s10875-008-9213-4"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Klangsinsirikul P, Carter GI, Byrne JL, Hale G, Russell NH. Campath-1G causes rapid depletion of circulating host dendritic cells (DCs) before allogeneic transplantation but does not delay donor DC reconstitution. Blood 99: 2586-2591, 2002.","DOI":"10.1182\/blood.V99.7.2586"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Simpson D. T-cell depleting antibodies: new hope for induction of allograft tolerance in bone marrow transplantation? BioDrugs 17: 147-154, 2003.","DOI":"10.2165\/00063030-200317030-00001"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Swee du S, Chng CL, Lim A. Clinical characteristics and outcome of thyroid storm: a case series and review of neuropsychiatric derangements in thyrotoxicosis. Endocr Pract 21: 182-189, 2015.","DOI":"10.4158\/EP14023.OR"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Angell TE, Lechner MG, Nguyen CT, Salvato VL, Nicoloff JT, LoPresti JS. Clinical features and hospital outcomes in thyroid storm: a retrospective cohort study. J Clin Endocrinol Metab 100: 451-459, 2015.","DOI":"10.1210\/jc.2014-2850"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/3\/65_5587-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T03:46:48Z","timestamp":1770436008000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/3\/65_5587-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,1]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5587-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,1]]},"article-number":"5587-25"}}